Literature DB >> 29070688

Structural Basis for Escape of Human Astrovirus from Antibody Neutralization: Broad Implications for Rational Vaccine Design.

Walter A Bogdanoff1, Edmundo I Perez1, Tomás López2, Carlos F Arias2, Rebecca M DuBois3.   

Abstract

Human astroviruses are recognized as a leading cause of viral diarrhea worldwide in children, immunocompromised patients, and the elderly. There are currently no vaccines available to prevent astrovirus infection; however, antibodies developed by healthy individuals during previous infection correlate with protection from reinfection, suggesting that an effective vaccine could be developed. In this study, we investigated the molecular mechanism by which several strains of human astrovirus serotype 2 (HAstV-2) are resistant to the potent HAstV-2-neutralizing monoclonal antibody PL-2 (MAb PL-2). Sequencing of the HAstV-2 capsid genes reveals mutations in the PL-2 epitope within the capsid's spike domain. To understand the molecular basis for resistance from MAb PL-2 neutralization, we determined the 1.35-Å-resolution crystal structure of the capsid spike from one of these HAstV-2 strains. Our structure reveals a dramatic conformational change in a loop within the PL-2 epitope due to a serine-to-proline mutation, locking the loop in a conformation that sterically blocks binding and neutralization by MAb PL-2. We show that mutation to serine permits loop flexibility and recovers MAb PL-2 binding. Importantly, we find that HAstV-2 capsid spike containing a serine in this loop is immunogenic and elicits antibodies that neutralize all HAstV-2 strains. Taken together, our results have broad implications for rational selection of vaccine strains that do not contain prolines in antigenic loops, so as to elicit antibodies against diverse loop conformations.IMPORTANCE Human astroviruses (HAstVs) infect nearly every person in the world during childhood and cause diarrhea, vomiting, and fever. In this study, we investigated how several strains of HAstV are resistant to a virus-neutralizing monoclonal antibody. We determined the crystal structure of the capsid protein spike domain from one of these HAstV strains and found that a single amino acid mutation induces a structural change in a loop that is responsible for antibody binding. Our findings reveal how viruses can escape antibody neutralization and provide insight for the rational design of vaccines to elicit diverse antibodies that provide broader protection from infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  astrovirus; neutralizing antibodies; structure-activity relationships; vaccines

Mesh:

Substances:

Year:  2017        PMID: 29070688      PMCID: PMC5730766          DOI: 10.1128/JVI.01546-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Astrovirus gastroenteritis.

Authors:  Douglas K Mitchell
Journal:  Pediatr Infect Dis J       Date:  2002-11       Impact factor: 2.129

2.  Characterization of human serotype 1 astrovirus-neutralizing epitopes.

Authors:  D M Bass; U Upadhyayula
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Successful intravenous immunoglobulin therapy for severe and persistent astrovirus gastroenteritis after fludarabine treatment in a patient with Waldenström's macroglobulinemia.

Authors:  M Björkholm; F Celsing; G Runarsson; J Waldenström
Journal:  Int J Hematol       Date:  1995-08       Impact factor: 2.490

Review 4.  Human astroviruses.

Authors:  Albert Bosch; Rosa M Pintó; Susana Guix
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Astrovirus gastroenteritis age distribution of antibody.

Authors:  J Kurtz; T Lee
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

6.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

Review 7.  Astrovirus infection in children.

Authors:  Jolan E Walter; Douglas K Mitchell
Journal:  Curr Opin Infect Dis       Date:  2003-06       Impact factor: 4.915

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  De Novo Sequencing and Resurrection of a Human Astrovirus-Neutralizing Antibody.

Authors:  Walter A Bogdanoff; David Morgenstern; Marshall Bern; Beatrix M Ueberheide; Alicia Sanchez-Fauquier; Rebecca M DuBois
Journal:  ACS Infect Dis       Date:  2016-03-14       Impact factor: 5.084

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  11 in total

1.  Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.

Authors:  Stanislav O Fedechkin; Natasha L George; Ana M Nuñez Castrejon; Joshua R Dillen; Lawrence M Kauvar; Rebecca M DuBois
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

Review 2.  Bovine Astrovirus-A Comprehensive Review.

Authors:  Qinghe Zhu; Bin Li; Dongbo Sun
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

3.  Isolation of Neutralizing Monoclonal Antibodies to Human Astrovirus and Characterization of Virus Variants That Escape Neutralization.

Authors:  Rafaela Espinosa; Tomás López; Walter A Bogdanoff; Marco A Espinoza; Susana López; Rebecca M DuBois; Carlos F Arias
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

4.  Protein Disulfide Isomerase A4 Is Involved in Genome Uncoating during Human Astrovirus Cell Entry.

Authors:  Nayeli Aguilar-Hernández; Lena Meyer; Susana López; Rebecca M DuBois; Carlos F Arias
Journal:  Viruses       Date:  2020-12-31       Impact factor: 5.048

Review 5.  Structural Insights into the Human Astrovirus Capsid.

Authors:  Matthew Ykema; Yizhi J Tao
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

6.  Human Astrovirus 1-8 Seroprevalence Evaluation in a United States Adult Population.

Authors:  Lena Meyer; Kevin Delgado-Cunningham; Nicholas Lorig-Roach; Jordan Ford; Rebecca M DuBois
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

Review 7.  Intra- and Cross-Species Transmission of Astroviruses.

Authors:  Shanley N Roach; Ryan A Langlois
Journal:  Viruses       Date:  2021-06-11       Impact factor: 5.048

8.  Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups.

Authors:  Christine R Fisher; David E Lowe; Todd G Smith; Yong Yang; Christina L Hutson; Christoph Wirblich; Gino Cingolani; Matthias J Schnell
Journal:  Cell Rep       Date:  2020-07-21       Impact factor: 9.423

9.  Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines.

Authors:  Mehdi R M Bidokhti; Karin Ullman; Anne Sofie Hammer; Trine Hammer Jensen; Mariann Chriél; Siddappa N Byrareddy; Claudia Baule
Journal:  Vaccines (Basel)       Date:  2019-08-02

Review 10.  Animal and human RNA viruses: genetic variability and ability to overcome vaccines.

Authors:  T G Villa; Ana G Abril; S Sánchez; T de Miguel; A Sánchez-Pérez
Journal:  Arch Microbiol       Date:  2020-09-28       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.